electroCore,

electroCore, Cost of Goods Sold

The Cost of Goods Sold (COGS) of electroCore, (ECOR) as of Oct 17, 2026 is 4.24 M USD. In the previous year, Cost of Goods Sold (COGS) was 3.79 M USD — a change of 12.13% (higher).

Cost of Goods Sold

4.24 MUSD

YoY

12.13%

Last updated:

Cost of Goods Sold (COGS) of electroCore, is 2025 4.24 M USD. Cost of Goods Sold (COGS) of electroCore, was 2024 3.79 M USD. It decreases by 12.13% higher compared to the previous year.

The electroCore, Cost of Goods Sold history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cost of Goods Sold
Date
Cost of Goods Sold
Jan 1, 2018
578,743.00 USD
Jan 1, 2019
1.16 M USD
Jan 1, 2020
1.74 M USD
Jan 1, 2021
1.39 M USD
Jan 1, 2022
1.62 M USD
Jan 1, 2023
2.80 M USD
Jan 1, 2024
3.79 M USD
Jan 1, 2025
4.24 M USD
The electroCore, Cost of Goods Sold history
YEARCost of Goods SoldYoY
4.24 MUSD+12.13%
3.79 MUSD+34.99%
2.80 MUSD+73.51%
1.62 MUSD+16.68%
1.39 MUSD-20.29%
1.74 MUSD+50.18%
1.16 MUSD+99.91%
578,743.00USD+11.61%
518,532.00USD+319.08%
123,731.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Cost of Goods Sold (COGS) of electroCore, is 4.24 M USD in 2025.

Cost of Goods Sold (COGS) of electroCore, changed from 3.79 M USD to 4.24 M USD, representing a 12.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cost of Goods Sold (COGS) electroCore, since 2006 – with annual values, charts, and detailed analysis.

COGS represents the direct costs attributable to the production of goods sold. It includes material and labor costs directly tied to the product.

Cost of Goods Sold (COGS)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cost of Goods Sold (COGS)'s electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — electroCore,

All Key Metrics — electroCore,